Navigation Links
Reportlinker Adds Pharmacodynamic Assays
Date:12/8/2009

NEW YORK, Dec. 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pharmacodynamic Assays

http://www.reportlinker.com/p0167260/Pharmacodynamic-Assays.html

Pharmacodynamic assays are assays that provide methods for quickly screening cell samples for a pharmacodynamic effect to a drug or test agent. These assays inform drug development decisions by providing evidence of drug action on molecular targets.

Pharmacodynamic assay development has become an increasingly lucrative area of product development for research supply companies, as demand for the assays has risen following recent introduction of Phase 0 trials by the FDA. Phase 0 trials are known as human microdosing studies and are designed to speed up the development of promising drugs by establishing early on whether they interact with their expected targets.

The NCI recently requested that qualified small businesses submit proposals to develop pharmacodynamic assays for measuring a number of high-priority molecular targets. (For a list of the targets of interest to NCI, see: http://sbir.cancer.gov/). NCI's goal is to support development of new rigorous, validated assays to measure molecular-level response to treatment, especially real-time assays that could be used to rapidly assess response to treatment during clinical trials.

This market report characterizes the rapidly growing pharmacodynamic assays market, including:

* Market segmentation by application

* Examination of validated assays and assays under development

* Quantitative U.S. and International market size analysis

* Analysis of market growth rates and future projections

* In-depth analysis of emerging trends and opportunities

* A critique of high-priority molecular targets for assay development

* Research product opportunities & suggestions

In summary, it provides detailed guidance for companies that wish to develop pharmacodynamic assays to supplement their traditional research supplies or bio-pharmaceutical product development.

I. Pharmacodynamics Assays

A. Definition

B. History

1. Impact of Phase 0 Legislation

2. SBIR Support of Pharmacodynamic Assay Development

C. Increasing Participation from Research Supply Companies

1. Natural Extension of Product Lines

2. A Response to Potential Profits

II. Market Segmentation of by Application

A. Streamlined Drug Development Processes for Pharmaceutical Companies

B. Phase 0 Clinical Trials

C. Patient Stratification during Clinical Trials (Phase I-IV)

D. Prediction of Cancer Re-Occurrence

E. Insights into the Basis of Cytotoxic Response to Existing Cancer Therapies

F. Pharmacodynamic Monitoring of Immunosuppressive Drugs

III. Market Environment

A. High Market Penetration Assays

B. Recently Validated Assays

C. Assays under Development

IV. High-priority Molecular Targets for Assay Development

V. Competitive Analysis

A. Early Entrants

B. Dominant Competitors

C. Recent Market Players

VI. Analysis of Grant Rates / Trends in Funding

A. Trailing 5 Year Analysis

B. Projected 5 Year Analysis

VII. Market Size Determination for Pharmacodynamic Assays

A. Methods

B. Worldwide Annual Market Size

C. U.S. Annual Market Size

VIII. Market Growth Rates & Trend Analysis

A. Experimental Approach

B. Growth Rates

C. Trend Analysis

IX. Market Projections

X. Product Development Opportunities & Suggestions

A. Pre-Clinical Applications (Research-Use Only)

1. Angiogenesis

2. DNA Damage/Apoptosis

3. Other

B. Clinical Applications

To order this report:

Biotechnology Industry: Pharmacodynamic Assays

More Market Research Report


Nicolas Bombourg
Reportlinker
Email: nbo@reportlinker.com
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker


'/>"/>
SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Reportlinker Adds Smart Glass: Technologies and Global Markets Report
2. Reportlinker Adds Synthetic Biology: Emerging Global Markets Report
3. Reportlinker Adds Proteomics: Technologies and Global Markets Report
4. Reportlinker Adds Nanomedicine Report
5. Reportlinker Adds Small Molecule Kinase Inhibitors Report
6. Reportlinker Adds Nanoporous Materials Report
7. Reportlinker Adds Membrane Bioreactors Report
8. Reportlinker Adds High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer) Report
9. Reportlinker Adds In Vitro Diagnostics in a Recession: IVD Market Forecasts, Analysis and Success Strategies Report
10. Reportlinker Adds World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Report
11. Reportlinker Adds Stem Cell Therapeutics Markets Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... BETHESDA, Md. , Jan. 18, 2017  Northwest ... company developing DCVax® personalized immune therapies for operable and ... Marnix Bosch , Chief Technical Officer of NW Bio, ... Thursday, January 19, 2017, at the Hyatt Regency Hotel ... Dr. Bosch will chair the session entitled "New Therapeutic ...
(Date:1/19/2017)... LAKES, N.J. , Jan. 18, 2017 BD (Becton, ... technology company, announced today that it will host a live webcast ... at 1 p.m. (ET). The webcast can be ... be available for replay through Tuesday, January 31, 2017. ... About BD BD ...
(Date:1/18/2017)... According to a new market research report "In situ Hybridization Market by ... (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global Forecast to 2021" published ... from USD 557.1 Million in 2016, growing at a CAGR of 5.8%. ... ... MarketsandMarkets Logo ...
(Date:1/18/2017)... Mass. , Jan. 18, 2017 ... applying mechanistic modeling to drug research and development, ... PhD, Co-Founder, President, and CEO of Applied BioMath, ... for Informatics and Modeling (BAGIM) Meeting on Thursday ... Cambridge , MA.   Dr. Burke,s ...
Breaking Biology Technology:
(Date:1/6/2017)... Jan. 5, 2017  Delta ID Inc., a leader ... technology for automotive at CES® 2017. Delta ID has ... to demonstrate the use of iris scanning as a ... the driver in a car, and as a way ... experience. Delta ID and Gentex will demonstrate ...
(Date:12/22/2016)... MOUNTAIN VIEW, Calif. , Dec. 20, 2016  As ... all levels, 23andMe, the leading personal genetics company, recently released ... Only Me . The book focuses on the topics ... the Next Generation Science Standards (NGSS) taught in elementary school ... the second in a series by illustrator Ariana Killoran ...
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic ... permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se ... tumor en 2017, con múltiples sitios previstos a lo largo de ... ... el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se ...
Breaking Biology News(10 mins):